The latest on menopausal hormone therapy and breast cancer

Prof Martha Hickey

writer

Prof Martha Hickey

Professor of Obstetrics and Gynaecology, University of Melbourne

Prof Mark Jenkins

writer

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Menopause is a normal life stage for women at around 51 years. Most women don’t need treatment for their symptoms, but around 13% of Australian women aged 50-69 take menopausal hormone therapy (sometimes called “hormone replacement therapy”).

This medication contains hormones that are normally low or absent after menopause, and reduces symptoms such as hot flushes and night sweats, which can be troublesome and persistent for some women.

But growing evidence over recent years has pointed to an increased risk of breast cancer associated with menopausal hormone therapy. This has already led some women to stop or avoid the treatment.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Andrew Scroop

Dr Andrew Scroop

Oral Corticosteroid Stewardship For Asthma – Why it is Important

Prof Brendon Yee

Prof Brendon Yee

GLP-1s For OSA

Dr Chris Bollen

Dr Chris Bollen

How-to Guide on Muscle Health Checks

Prof Rodney Baber AM

Prof Rodney Baber AM

MHT For Women With History or Risk of Cancer

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof Martha Hickey

writer

Prof Martha Hickey

Professor of Obstetrics and Gynaecology, University of Melbourne

Prof Mark Jenkins

writer

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

Test your knowledge

Recent articles

Latest GP poll

AHPRA's new CEO says he is committed to improving how complaints are handled. How likely is this to succeed?

Likely to succeed

0%

Unlikely to succeed

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease